Washington Buried the Science on Alcohol. Now Congress Is Making It Permanent.

On Tuesday, a study nearly two years in the making appeared in the Journal of Studies on Alcohol and Drugs without the name of the agency that funded it. That agency — the Substance Abuse and Mental Health Services Administration — had commissioned the research in 2023 to inform updated federal dietary guidelines. It spent roughly two years overseeing the review. Then the Trump administration decided not to feature the study’s findings in those guidelines, the House Oversight Committee called the work “irretrievably flawed,” and the administration sent back a clear signal: this research was not going to see the light of day through official channels.

So the researchers took it to a journal instead. They stripped the government affiliation from the paper. On Tuesday, it published anyway.

By Thursday morning, the House Appropriations Committee had voted to make sure that kind of science never reaches a journal in the first place. Tucked inside an HHS spending bill passed this week is a provision prohibiting the SAMHSA advisory panel that ran the study from conducting any work to “study, analyze, consider or report” on adult alcohol consumption — now defined as outside the panel’s purview, which is formally limited to underage drinking prevention.

That’s the sequence. A study gets funded with public money. The study finds something the alcohol industry doesn’t like. The administration refuses to publish it. Congress bans the research program. In two weeks, you go from scientific suppression to statutory erasure.

Robert Vincent, who served as a former associate administrator for alcohol prevention and treatment policy at SAMHSA and helped oversee the study, put it directly in an editorial accompanying the paper: “These findings are not radical. They are rigorous — and commercially threatening.”

He is right on both counts.

The findings themselves are not controversial — they’re just inconvenient

The study’s core conclusion is not new. The scientific consensus on alcohol and health has been moving in this direction for years. What makes the SAMHSA study significant is not that it discovered something revolutionary — it’s that it was official, rigorous, and federally commissioned, which meant it carried the weight that would force updates to the Dietary Guidelines for Americans. That’s the document that millions of doctors use to counsel patients. That’s the document that food labeling policy references. That’s the document the alcohol industry has spent considerable resources attempting to shape.

The study found that there is no net health benefit from alcohol at any level of consumption. Even one drink per day — a threshold widely marketed as moderate, healthy, even cardioprotective — raises the risk of death from liver cirrhosis, esophageal cancer, oral cancer, and injury-related causes. The “J-curve” hypothesis — the longstanding popular belief that light drinking protects the heart — does not hold up when you control for confounders and examine all-cause mortality. At fourteen drinks per week, men face approximately a one-in-twenty-five chance of dying from an alcohol-related cause over their lifetime. Women reach elevated risk at lower thresholds.

This is not new information to researchers. The World Health Organization updated its position years ago: no level of alcohol consumption is safe for health. The Canadian Centre on Substance Use and Addiction released similar guidance in 2023. A Lancet analysis in 2018 concluded there is no safe level of alcohol. What was new — and what made the American study politically explosive — was that it had been commissioned by the United States government, run by a federal agency, and was positioned to directly inform the Dietary Guidelines for Americans 2025–2030 update.

The guidelines came out anyway, without the study. They said Americans should consume “less alcohol for better overall health” — watered-down language that stopped well short of the study’s findings. The trade associations that represent beer, wine, and liquor producers had spent months lobbying against any tightening of the guidelines. The House Oversight Committee obliged them by declaring the study “irretrievably flawed” in January — without identifying a single methodological error in the peer-reviewed work.

They said Americans should consume “less alcohol for better overall health” — watered-down language that stopped well short of the study’s findings.

The denial that doesn’t hold up

When the JSAD paper appeared Tuesday, HHS issued a statement: the study was “NOT commissioned by, NOR reviewed, approved, or cleared by” SAMHSA.

Every word of that sentence is technically true. The study, as published in JSAD, was submitted without SAMHSA listed as funder. SAMHSA did not review or approve the final version that appeared in the journal.

But SAMHSA oversaw the scientific review from 2023 to 2025. Every dollar of the research came from American taxpayers, channeled through HHS. The study’s authors are the same scientists who were running a federal panel on alcohol and health. The methodology, the data sources, the peer review process — all of it was conducted under government auspices. The only thing that changed is who signed off on the version that went to publication.

This kind of technical denial works in a press release. It doesn’t work as a description of what actually happened. What actually happened is that the government funded the work, received conclusions it didn’t like, and refused to claim ownership of the result. The scientists, rather than see years of taxpayer-funded research disappear, published it in the only venue available to them: independent peer review.

The House Appropriations provision, which landed Thursday, is a more honest response — at least in terms of what it reveals about intent. It doesn’t pretend the study was flawed or that the science was wrong. It simply prohibits the research from happening again. If you can’t control the findings, you eliminate the program.

What this has cost, and what it continues to cost

Alcohol kills approximately 178,000 Americans every year, according to federal estimates — more than any illicit drug, and more than the entire overdose crisis at its 2023 peak. The pandemic accelerated the toll: alcohol-induced deaths spiked roughly 30 percent during COVID, reaching 105,400 in 2022. Alcohol kills roughly as many Americans annually as drug overdoses did at the height of the fentanyl crisis. It kills more. It does so without the policy apparatus of an emergency, without the rhetorical urgency of a crisis, and without the public health infrastructure that has been built up around opioids.

Part of the reason is that the science of alcohol’s harms has been persistently clouded by the “moderate drinking is healthy” narrative — a narrative the dietary guidelines helped manufacture. That narrative is not neutral. It shapes what physicians say in exam rooms, what patients believe about their own consumption, and what insurers are willing to fund in the way of prevention and treatment. The Dietary Guidelines for Americans are not background noise; they are the official voice of the American government on what is safe to eat and drink. When that voice is captured by industry lobbying, real people are harmed.

They are harmed in ways that look unremarkable: liver disease that develops slowly, a cancer diagnosis in a person who drank what they were told was a safe amount, a car accident involving a driver who was under the limit but not safe to drive. The crisis of alcohol doesn’t look like the fentanyl crisis. It doesn’t produce dramatic visible statistics — no monthly CDC provisional counts, no photo of Narcan kits. It produces death in slow motion, distributed across millions of households that were told the product they were using was, within reason, fine.

The suppression of this study is not just a Washington insider story about who won a bureaucratic fight. It’s a story about who gets to set the terms of a public health conversation, and what happens when the answer is “the industry whose product is under review.” The WHO said no safe level. Canada said no safe level. The federal scientists the U.S. government hired to answer the question said no safe level. The government’s response was to hide the study, claim it never commissioned it, and now pass legislation to prevent similar research.

The government’s response was to hide the study, claim it never commissioned it, and now pass legislation to prevent similar research.

What the field should do — and what Rize sees

The immediate implication is practical: treatment providers, harm reduction workers, and recovery navigators should not wait for federal guidance to update. The evidence is clear. The guidelines are not. Providers working with patients who drink — which is virtually everyone working in addiction care, since alcohol is involved in a huge proportion of polysubstance presentations — should counsel based on what the peer-reviewed literature says, not what the dietary guidelines allow.

There is also a longer-term implication for how the field talks about alcohol publicly. The term “alcohol use disorder” affects roughly 29 million Americans, according to SAMHSA’s own survey data. Fewer than 10 percent of them ever receive a prescription for a medication to treat it. GLP-1 drugs like semaglutide, which STAT News documented in its “Deadliest Drug” series this spring, show genuine promise for reducing consumption and craving — and yet the evidence base is being built in an environment where the government is actively suppressing the foundational research that would make treating alcohol a clinical priority.

For people navigating recovery resources at /newsroom/substances/alcohol, the practical answer is: your provider’s caution is well-founded, the science supports it, and the reason you’re not hearing it from official sources is not because researchers disagree. It’s because the industry that sells the product has more influence over federal science communications than the scientists who conducted the work.

Robert Vincent’s editorial said the challenges of alcohol policy “are not rooted in scientific uncertainty.” He’s right. The uncertainty is manufactured. The science has been in. The question now is whether the field is willing to act on it without waiting for a government that has, this week, voted to stop asking.

Congress isn’t going to name this what it is. Someone has to.